caldooninvestment

CNST - Bought @ $34

NASDAQ:CNST   None
-MorphoSys (MOR) announced its $1.7 billion plan to acquire cancer treatment biotech Constellation Pharmaceuticals (CNST) on Wednesday and CNST stock rocketed to a four-month high.

-In morning trading on the stock market today, CNST stock soared 66.6% near 33.72.

-Under the terms of the deal, MorphoSys will pay $34 per share of CNST stock.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.